Hematopoietic Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem CellsTransplantation, AutologousTransplantation, HomologousStem CellsBone MarrowTransplantation ConditioningBone Marrow CellsWhole-Body IrradiationGraft vs Host DiseaseHematopoiesisStem Cell TransplantationGraft SurvivalAntigens, CD34Hematologic NeoplasmsPeripheral Blood Stem Cell TransplantationCombined Modality TherapyHematopoietic Stem Cell MobilizationMelphalanTreatment OutcomeCyclophosphamideMultiple MyelomaLiver TransplantationCell DifferentiationTransplantation ChimeraDisease-Free SurvivalMyeloablative AgonistsRetrospective StudiesTissue DonorsMice, Inbred C57BLCell LineageLymphoma, Non-HodgkinLeukemiaColony-Forming Units AssayRecurrenceRemission InductionImmunosuppressive AgentsSalvage TherapyStem Cell NicheAnemia, AplasticBusulfanAdult Stem CellsHistocompatibility TestingEmbryonic Stem CellsKidney TransplantationBone and BonesSurvival RateSurvival AnalysisHistocompatibilityFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsTransplantation, IsogeneicCells, CulturedTime FactorsRadiation ChimeraBone Marrow PurgingCell SeparationStem Cell FactorCord Blood Stem Cell TransplantationMesenchymal Stem Cell TransplantationMultipotent Stem CellsFetal BloodLeukemia, Myeloid, AcutePluripotent Stem CellsTransplantation ImmunologyCell ProliferationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionHeart TransplantationPrognosisGranulocyte Colony-Stimulating FactorMesenchymal Stromal CellsT-LymphocytesCell TransplantationMice, SCIDHematopoietic SystemBone Marrow DiseasesSevere Combined ImmunodeficiencyChimerismMyelodysplastic SyndromesHepatic Veno-Occlusive DiseaseLung TransplantationHematologic DiseasesHLA AntigensAntineoplastic AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, MyeloidMice, KnockoutImmunosuppressionOrgan TransplantationAntigens, CDAcute DiseaseInduced Pluripotent Stem CellsGraft vs Leukemia EffectMice, TransgenicChimeraLymphocyte DepletionNeural Stem CellsMesonephros